Table 1 Level of agreement by question and priority item

Priority No	Questions and priority items	Agreement
Priority No	Questions and priority items	Number out of 37	%
	1. Factors considered in prescribing pharmacotherapy(ies)
1	Evidence	32	86
2	Patient preference	30	81
3	Patient experience	29	78
4	Patient needs	28	76
5	Patient history	27	73
6	Patient’s clinical suitability	28	76
7	Potential drug interactions/side effects	28	76
	Mean	29	78
	Kendall’s W (coefficient of concordance)	0.68
	Statistical significance	p<0.001
	First principal component	79.4% of variance
	2. Combinations of pharmacotherapies prescribed based on
1	Failed attempt with monotherapy	30	81
2	Patients with breakthrough cravings	30	81
3	Level of dependence	27	73
4	Multiple failed attempts	31	84
5	Patients with nicotine withdrawal	31	84
	Mean	29	78
	Kendall’s W (coefficient of concordance)	0.70
	Statistical significance	p<0.001
	First principal component	78.6% of variance
	3. Specific combinations of pharmacotherapies: main categories
1	Two or more forms of NRT	34	92
2	Bupropion + form of NRT	34	92
	Mean	34	92
	4. Specific combinations of pharmacotherapies: subcategories
	2 or more forms of NRT
1	Patch + gum	34	92
2	Patch + inhaler	32	86
3	Patch + lozenge	32	86
	Mean	33	88
	Bupropion + form of NRT
1	Bupropion + patch	33	89
2	Bupropion + gum	33	89
	Mean	33	89
	5. Impact of comorbities on the selection of pharmacotherapy(ies)
1	Contraindications	36	97
2	Specific pharmacotherapies useful for certain comorbidities	36	97
3	Dual purpose medications	36	97
	Mean	36	97
	6. Frequency of monitoring determined by
1	Patient needs	36	97
2	Type of pharmacotherapy	36	97
	Mean	36	97